Bone Therapeutics Gains Funding for Tissue Engineered Bone Implants
The company and its partners formed TrueBone3D to develop biologically active, patient-tailored bioresorbable implants enriched with ALLOB....
The company and its partners formed TrueBone3D to develop biologically active, patient-tailored bioresorbable implants enriched with ALLOB....
Funds will primarily be allocated to product development and expanding commercialization of a full platform of shoulder replacement products....
The new financing allows the company to fulfill rising demand for single-use procedure kits for children with orthopedic issues....
The company's FiberCel, ViBone and OsteGro V viable bone matrices address orthopedic and spine applications....
The financing support plans to commercialize plans for the V-STRUT Vertebral Implant in the U.S. spinal fracture market....
The company posted 2018 and 2019 revenue of $90.8 million and $95.9 million, respectively, growing +5.6% year over year....
The number of funding disclosures in 2020 demonstrates investment interest in orthopedics’ smaller companies and novel technologies even amongst COVID-19s...
With Osso VR's virtual reality surgical training curriculum, surgeons can train and assess themselves on the workflow of procedures at...
The $2 million grant will fund a Phase I/II clinical trial of HST-003 for regeneration of cartilage in the knee....
Financing will provide 7D with the capital to grow existing operations, further develop new products and continue its expansion into...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.